These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 18509854)

  • 1. Genetic and pharmacological manipulations of the CB(1) receptor alter ethanol preference and dependence in ethanol preferring and nonpreferring mice.
    Vinod KY; Yalamanchili R; Thanos PK; Vadasz C; Cooper TB; Volkow ND; Hungund BL
    Synapse; 2008 Aug; 62(8):574-81. PubMed ID: 18509854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lack of CB1 receptors prevents neuroadapatations of both NMDA and GABA(A) receptors after chronic ethanol exposure.
    Warnault V; Houchi H; Barbier E; Pierrefiche O; Vilpoux C; Ledent C; Daoust M; Naassila M
    J Neurochem; 2007 Aug; 102(3):741-52. PubMed ID: 17442049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of the cannabinoid CB1 receptor and alcohol dependence: preclinical evidence and preliminary clinical data.
    Maccioni P; Colombo G; Carai MA
    CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):55-9. PubMed ID: 20201816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol-seeking behavior in rats.
    Cippitelli A; Bilbao A; Hansson AC; del Arco I; Sommer W; Heilig M; Massi M; Bermúdez-Silva FJ; Navarro M; Ciccocioppo R; de Fonseca FR;
    Eur J Neurosci; 2005 Apr; 21(8):2243-51. PubMed ID: 15869521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid receptor agonist-stimulated [35S]guanosine triphosphate gammaS binding in the brain of C57BL/6 and DBA/2 mice.
    Basavarajappa BS; Hungund BL
    J Neurosci Res; 2001 May; 64(4):429-36. PubMed ID: 11340650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innate difference in the endocannabinoid signaling and its modulation by alcohol consumption in alcohol-preferring sP rats.
    Vinod KY; Maccioni P; Garcia-Gutierrez MS; Femenia T; Xie S; Carai MA; Manzanares J; Cooper TB; Hungund BL; Colombo G
    Addict Biol; 2012 Jan; 17(1):62-75. PubMed ID: 21309960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotypic differences in brain dopamine receptor function in the DBA/2J and C57BL/6J inbred mouse strains.
    Ng GY; O'Dowd BF; George SR
    Eur J Pharmacol; 1994 Nov; 269(3):349-64. PubMed ID: 7895774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CB1 knockout mice display significant changes in striatal opioid peptide and D4 dopamine receptor gene expression.
    Gerald TM; Ward GR; Howlett AC; Franklin SO
    Brain Res; 2006 Jun; 1093(1):20-4. PubMed ID: 16684513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of CB1 receptors in sweet versus fat reinforcement: effect of CB1 receptor deletion, CB1 receptor antagonism (SR141716A) and CB1 receptor agonism (CP-55940).
    Ward SJ; Dykstra LA
    Behav Pharmacol; 2005 Sep; 16(5-6):381-8. PubMed ID: 16148442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference.
    Hansson AC; Bermúdez-Silva FJ; Malinen H; Hyytiä P; Sanchez-Vera I; Rimondini R; Rodriguez de Fonseca F; Kunos G; Sommer WH; Heilig M
    Neuropsychopharmacology; 2007 Jan; 32(1):117-26. PubMed ID: 16482090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endogenous cannabinoid system modulates nicotine reward and dependence.
    Merritt LL; Martin BR; Walters C; Lichtman AH; Damaj MI
    J Pharmacol Exp Ther; 2008 Aug; 326(2):483-92. PubMed ID: 18451315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-Substituted pyrazole analogs of the cannabinoid type 1 (CB₁) receptor antagonist rimonabant: cannabinoid agonist-like effects in mice via non-CB₁, non-CB₂ mechanism.
    Wiley JL; Selley DE; Wang P; Kottani R; Gadthula S; Mahadeven A
    J Pharmacol Exp Ther; 2012 Feb; 340(2):433-44. PubMed ID: 22085649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological manipulation of CB1 receptor function alters development of tolerance to alcohol.
    Nowak KL; Vinod KY; Hungund BL
    Alcohol Alcohol; 2006; 41(1):24-32. PubMed ID: 16216824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Manipulation of fatty acid amide hydrolase functional activity alters sensitivity and dependence to ethanol.
    Vinod KY; Sanguino E; Yalamanchili R; Manzanares J; Hungund BL
    J Neurochem; 2008 Jan; 104(1):233-43. PubMed ID: 17944864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat.
    Craft RM; Wakley AA; Tsutsui KT; Laggart JD
    J Pharmacol Exp Ther; 2012 Mar; 340(3):787-800. PubMed ID: 22182934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The G protein-coupled cannabinoid-1 (CB1) receptor of mammalian brain: inhibition by phthalate esters in vitro.
    Bisset KM; Dhopeshwarkar AS; Liao C; Nicholson RA
    Neurochem Int; 2011 Oct; 59(5):706-13. PubMed ID: 21763743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of cannabinoid type 1 receptors in dopamine D2 receptor knockout mice is reversed by chronic forced ethanol consumption.
    Thanos PK; Gopez V; Delis F; Michaelides M; Grandy DK; Wang GJ; Kunos G; Volkow ND
    Alcohol Clin Exp Res; 2011 Jan; 35(1):19-27. PubMed ID: 20958329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid-1 (CB1) receptors regulate colonic propulsion by acting at motor neurons within the ascending motor pathways in mouse colon.
    Sibaev A; Yüce B; Kemmer M; Van Nassauw L; Broedl U; Allescher HD; Göke B; Timmermans JP; Storr M
    Am J Physiol Gastrointest Liver Physiol; 2009 Jan; 296(1):G119-28. PubMed ID: 19033531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethanol self-administration is regulated by CB1 receptors in the nucleus accumbens and ventral tegmental area in alcohol-preferring AA rats.
    Malinen H; Hyytiä P
    Alcohol Clin Exp Res; 2008 Nov; 32(11):1976-83. PubMed ID: 18782338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central and peripheral consequences of the chronic blockade of CB1 cannabinoid receptor with rimonabant or taranabant.
    Martín-García E; Burokas A; Martín M; Berrendero F; Rubí B; Kiesselbach C; Heyne A; Gispert JD; Millán O; Maldonado R
    J Neurochem; 2010 Mar; 112(5):1338-13351. PubMed ID: 20028452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.